Christopher M. Yea
2019
In 2019, Christopher M. Yea earned a total compensation of $1.4M as Chief Development Officer at Carbylan Therapeutics, a 73% increase compared to previous year.
Compensation breakdown
| Bonus | $174,596 |
|---|---|
| Option Awards | $891,350 |
| Salary | $341,093 |
| Other | $20,466 |
| Total | $1,427,505 |
Yea received $891.4K in option awards, accounting for 62% of the total pay in 2019.
Yea also received $174.6K in bonus, $341.1K in salary and $20.5K in other compensation.
Rankings
In 2019, Christopher M. Yea's compensation ranked 7,555th out of 13,971 executives tracked by ExecPay. In other words, Yea earned more than 45.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,555 out of 13,971 | 46th |
Division Manufacturing | 2,938 out of 5,695 | 48th |
Major group Chemicals And Allied Products | 1,106 out of 2,194 | 50th |
Industry group Drugs | 942 out of 1,880 | 50th |
Industry Pharmaceutical Preparations | 696 out of 1,392 | 50th |
Source: SEC filing on August 25, 2020.
Yea's colleagues
We found three more compensation records of executives who worked with Christopher M. Yea at Carbylan Therapeutics in 2019.